المؤلفون: Di Lorenzo G; Dipartimento di Endocrinologia ed Oncologia Clinica e Molecolare, Università Federico II, Napoli, Italy. giuseppedilorenzoncol@hotmail.com, Cartenì G, Autorino R, Bruni G, Tudini M, Rizzo M, Aieta M, Gonnella A, Rescigno P, Perdonà S, Giannarini G, Pignata S, Longo N, Palmieri G, Imbimbo C, De Laurentiis M, Mirone V, Ficorella C, De Placido S

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2009 Sep 20; Vol. 27 (27), pp. 4469-74. Date of Electronic Publication: 2009 Aug 03.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Benzenesulfonates/*therapeutic use , Carcinoma, Renal Cell/*drug therapy , Kidney Neoplasms/*drug therapy , Pyridines/*therapeutic use, Adult ; Aged ; Carcinoma, Renal Cell/secondary ; Female ; Humans ; Indoles/therapeutic use ; Kidney Neoplasms/secondary ; Male ; Middle Aged ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Pyrroles/therapeutic use ; Sorafenib ; Sunitinib